Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Henza ApS
APS
Active
Advertising protection
CVR 40017232
Stillingvej 107, 8471
Sabro
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 7 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Henza ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
144
374
354
293
82
Staff expenses
-0
-0
-0
-0
-0
EBITDA
144
374
354
293
82
Depreciation & amort.
-65
-65
-65
-65
-65
EBIT
79
309
289
228
17
Net financials
-23
-11
-51
11
0
Profit before tax
56
298
238
239
17
Tax
12
66
53
53
4
Net profit
44
232
186
186
13
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
740
803
930
1.171
1.101
Equity
107
340
525
712
725
Long-term debt
0
0
0
0
0
Short-term debt
614
438
373
422
332
Total debt
614
438
373
422
332
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2025
Equity ratio
65.9%
This company
38.2%
Market median
+73% vs market
2021
2025
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
2021
2025
Net profit margin (of gross profit)
16.4%
This company
2021
2025
Asset turnover (of gross profit)
0.07×
This company
2021
2025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Henza ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
